Anteris Technologies Positioned To Capture 4%-5% Of US Transcatheter Valve Replacement Market By 2030: Analyst - Abbott Laboratories ( NYSE:ABT ) , Anteris Technologies ( NASDAQ:AVR )
Barclays analyst Matt Miksic initiated coverage on Anteris Technologies Global Corp. AVR with a Positive rating and a forecast of $22. The analyst notes that Anteris Technologies' DurAVR valve system is expected to become the second balloon-expandable transcatheter valve replacement ( BEV TAVR ) ...
https://www.benzinga.com/trading-ideas/movers/25/01/42859544/anteris-technologies-positioned-to-capture-4-5-of-us-transcatheter-valve-replacement-market-